
Join to View Full Profile
13400 E Shea BlvdScottsdale, AZ 85259
Phone+1 480-301-8000
Fax+1 858-657-7259
Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
All India Institute of Medical SciencesClass of 2007
Certifications & Licensure
AZ State Medical License 2025 - 2027
CA State Medical License 2015 - 2027
MN State Medical License 2011 - 2016
IA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Clinical Trials
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission Start of enrollment: 2022 Oct 05
Roles: Contact, Principal Investigator
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease Start of enrollment: 2024 Apr 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- Yield of Advanced Neoplasia at Second Post-polypectomy Surveillance Colonoscopy: A Systematic Review and Meta-analysis.Pooja Pandita, Yi Le, Mehul Trivedi, Karen Heskett, Joshua Demb
Clinical Gastroenterology and Hepatology. 2025-12-01 - 2 citationsComparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.Dhruv Ahuja, Kuan-Hung Yeh, Sagar B Patel, Han Hee Lee, Shane W Goodwin
Clinical Gastroenterology and Hepatology. 2025-07-28 - Guselkumab for Crohn's disease: the IL-23 blockade revolution.Claudia Dziegielewski, Siddharth Singh
Lancet. 2025-07-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









